Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils

Am J Physiol Cell Physiol. 2009 Apr;296(4):C857-67. doi: 10.1152/ajpcell.00454.2008. Epub 2009 Jan 28.

Abstract

We have recently reported that disruption of the actin cytoskeleton enhanced N-formylmethionyl-leucyl-phenylalanine (fMLP)-stimulated granule exocytosis in human neutrophils but decreased plasma membrane expression of complement receptor 1 (CR1), a marker of secretory vesicles. The present study was initiated to determine if reduced CR1 expression was due to fMLP-stimulated endocytosis, to determine the mechanism of this endocytosis, and to examine its impact on neutrophil functional responses. Stimulation of neutrophils with fMLP or ionomycin in the presence of latrunculin A resulted in the uptake of Alexa fluor 488-labeled albumin and transferrin and reduced plasma membrane expression of CR1. These effects were prevented by preincubation of the cells with sucrose, chlorpromazine, or monodansylcadaverine (MDC), inhibitors of clathrin-mediated endocytosis. Sucrose, chlorpromazine, and MDC also significantly inhibited fMLP- and ionomycin-stimulated specific and azurophil granule exocytosis. Disruption of microtubules with nocodazole inhibited endocytosis and azurophil granule exocytosis stimulated by fMLP in the presence of latrunculin A. Pharmacological inhibition of phosphatidylinositol 3-kinase, ERK1/2, and PKC significantly reduced fMLP-stimulated transferrin uptake in the presence of latrunculin A. Blockade of clathrin-mediated endocytosis had no significant effect on fMLP-stimulated phosphorylation of ERK1/2 in neutrophils pretreated with latrunculin A. From these data, we conclude that the actin cytoskeleton functions to limit microtubule-dependent, clathrin-mediated endocytosis in stimulated human neutrophils. The limitation of clathrin-mediated endocytosis by actin regulates the extent of both specific and azurophilic granule exocytosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Actins / metabolism*
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cadaverine / analogs & derivatives
  • Cadaverine / pharmacology
  • Chlorpromazine / pharmacology
  • Clathrin / metabolism*
  • Endocytosis* / drug effects
  • Exocytosis
  • Humans
  • Ionomycin / pharmacology
  • Microtubules / metabolism*
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophil Activation* / drug effects
  • Neutrophils / drug effects
  • Neutrophils / enzymology
  • Neutrophils / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Receptors, Complement 3b / metabolism
  • Secretory Vesicles / metabolism
  • Serum Albumin, Bovine / metabolism
  • Sucrose / pharmacology
  • Thiazolidines / pharmacology
  • Transferrin / metabolism
  • Tubulin Modulators / pharmacology

Substances

  • Actins
  • Bridged Bicyclo Compounds, Heterocyclic
  • CR1 protein, human
  • Clathrin
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Receptors, Complement 3b
  • Thiazolidines
  • Transferrin
  • Tubulin Modulators
  • Serum Albumin, Bovine
  • Ionomycin
  • Sucrose
  • N-Formylmethionine Leucyl-Phenylalanine
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • monodansylcadaverine
  • Cadaverine
  • latrunculin A
  • Chlorpromazine